Drug intelligence / Profile preview

Collosun

Development stage
Unknown
Lead developer
Mahakam Beta Farma
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Topical
01

Overview

Collosun is an over-the-counter (OTC) topical sunscreen cream developed and marketed by Mahakam Beta Farma. It is formulated to protect the skin from the deleterious effects of ultraviolet (UV) radiation, including both UVA and UVB rays, which are responsible for sunburn (erythema) and premature skin aging (photoaging). The formulation utilizes a synergistic combination of chemical UV filters, such as ethylhexyl methoxycinnamate and oxybenzone, and physical blockers like titanium dioxide. Ethylhexyl methoxycinnamate primarily absorbs UVB radiation, while oxybenzone provides broad-spectrum protection by absorbing both UVA and UVB. Titanium dioxide acts as a physical barrier that reflects and scatters UV rays. Furthermore, Collosun contains soluble collagen, which serves as a skin-conditioning and moisturizing agent to help maintain skin elasticity and counteract the drying effects of sun exposure.

Brand names
Collosun

Beyond the preview

Go deeper on Collosun.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collosun.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call